MedPath

Canadian Immunization Research Network

🇨🇦Canada
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.phoenix.com.tr

Clinical Trials

7

Active:1
Completed:5

Trial Phases

3 Phases

Phase 2:2
Phase 4:4
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 4
4 (57.1%)
Phase 2
2 (28.6%)
Not Applicable
1 (14.3%)

Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies

Not Applicable
Not yet recruiting
Conditions
Preventable Disease, Vaccine
First Posted Date
2024-07-08
Last Posted Date
2025-02-12
Lead Sponsor
Canadian Immunization Research Network
Target Recruit Count
600
Registration Number
NCT06489964
Locations
🇨🇦

Dalhousie University, Halifax, Nova Scotia, Canada

Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity

Phase 2
Active, not recruiting
Conditions
COVID-19
Interventions
First Posted Date
2021-05-20
Last Posted Date
2025-03-18
Lead Sponsor
Canadian Immunization Research Network
Target Recruit Count
669
Registration Number
NCT04894435
Locations
🇨🇦

Royal Inland Hospital, Kamloops, British Columbia, Canada

🇨🇦

Penticton Regional Hospital, Penticton, British Columbia, Canada

🇨🇦

BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada

and more 5 locations

Adolescent MenACWY Booster Study

Phase 4
Completed
Conditions
Meningococcal Disease, Invasive
First Posted Date
2018-10-03
Last Posted Date
2022-03-11
Lead Sponsor
Canadian Immunization Research Network
Target Recruit Count
244
Registration Number
NCT03694405
Locations
🇨🇦

Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada

🇨🇦

Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada

🇨🇦

Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada

CT18 Infant Influenza Priming Study in Vaccine Naive Infants

Phase 2
Completed
Conditions
Influenza
First Posted Date
2018-09-13
Last Posted Date
2023-03-28
Lead Sponsor
Canadian Immunization Research Network
Target Recruit Count
159
Registration Number
NCT03669627
Locations
🇨🇦

Vaccine Evaluation Center, BC Children's Hospital, Vancouver, British Columbia, Canada

🇨🇦

IWK Health Centre, Halifax, Nova Scotia, Canada

🇨🇦

Research Institute of the McGill University health Centre, Montréal, Quebec, Canada

and more 1 locations

Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction

Phase 4
Completed
Conditions
Healthy
Interventions
Biological: Meningococcal B
Biological: High-Dose TIV
Biological: Tdap (tetanus-diphtheria-acellular pertussis)
Biological: Meningococcal ACWY
Biological: Herpes Zoster
Biological: Travel Health (Hepatitis A, Hepatitis B, Typhoid Fever)
First Posted Date
2016-08-16
Last Posted Date
2024-12-16
Lead Sponsor
Canadian Immunization Research Network
Target Recruit Count
2404
Registration Number
NCT02868970
Locations
🇨🇦

IWK Health Centre, Halifax, Nova Scotia, Canada

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath